Table 1.
General description of the studies included
| Author | Year | Clinical type | Conditions assessed for HPV | Detection method | OLP (n/N) | Control (n/N) | HPV genotypes |
|---|---|---|---|---|---|---|---|
| Jontell et al.[13] | 1990 | OLP (e) | OLP | PCR, SBH | 13/20 | NA | HPV6, 11, 16 and 18 |
| Szarka et al.[14] | 2009 | EA-OLP, non-EA-OLP | OSCC, OLP.OL | PCR | 39/119 | 3/72 | HPV 6, 11, 16, 18, 31, 32, 33, 39, 51, 55, 57 |
| Mattila et al.[15] | 2012 | OLP (e) | OLP | Luminex-assay | 13/82 | NA | HPV6, 11, 16, 31, 33, 58, 66 |
| Sahebjamiee et al.[16] | NA | OLP | PCR | 11/40 | 5/40 | HPV16, 18 | |
| Gomez-Armayones et al.[17] | 2019 | NA | OLP, OSCC | PCR | 1/41 | NA | HPV16, HPV18 |
n: Numbers of HPV-positive subjects, N: Numbers of total subjects, PCR: Polymerase chain reaction, SBH: Southern blot hybridization, NA: Not available, OLP(e): Erosive oral lichen planus, HPV: Human papillomavirus, OSCC: Oral squamous cell carcinoma, EA: Erosive-atrophic